Efficacy of oral moxidectin against susceptible and resistant isolates of Dirofilaria immitis in dogs

Efficacy of oral moxidectin against susceptible and resistant isolates of Dirofilaria immitis in dogs

Abstract Background Monthly topical and sustained-release injectable formulations of moxidectin are currently marketed; however, an oral formulation, while approved at a dose of 3 μg/kg, is not currently marketed in the United States. Although resistance of heartworms to all macrocyclic lactone (ML)...

Full description

Bibliographic Details
Main Authors: Tom L. McTier, Robert H. Six, Aleah Pullins, Sara Chapin, John W. McCall, Douglas Rugg, Steven J. Maeder, Debra J. Woods
Format: Article
Language:English
Published: BMC 2017-11-01
Series:Parasites & Vectors
Subjects:
Moxidectin
Oral
Heartworm
Dirofilaria immitis
Macrocyclic lactone
Resistance
Online Access:http://link.springer.com/article/10.1186/s13071-017-2429-5

Internet

http://link.springer.com/article/10.1186/s13071-017-2429-5

Similar Items